PERESWETOFF-MORATH, LENA,CARLSSON, ANDERS,PERESWETOFF-MORATH, Lena,CARLSSON, Anders
申请号：
RSP20120246
公开号：
RS52311B
申请日:
2005.05.06
申请国别(地区):
RS
年份:
2012
代理人:
摘要：
A pharmaceutical composition for the treatment of rhinitis by nasal or ocular administration comprises zwitterionic cetirizine, polar lipid liposome, a pharmaceutical acceptable aqueous carrier and, optionally, a pharmaceutically acceptable buffer capable of providing a pH of from pH 4.0 to pH 8.0, with the proviso that, if the polar lipid comprises phospholipid, the amount of phospholipid in the composition from is from 10 mg per mL to 120 mg per mL. Also disclosed are methods for its preparation and methods for treating rhinitis by its nasal or ocular administration.Homogena farmaceutska kompozicija pogodna za lečenje rinitisa nazalnim ili okularnim davajem, koja sadrži cviter jon cetirizina, polarni lipidni lipozom i farmaceutski-prihvatljiv vodeni nosač, u kojoj koncentracija cetirizina varira ali ne više od +50% kada se poredi sa koncentracijama unutar i izvan struktura lipozoma.Prijava sadrži još 59 patentnih zahteva.
